Updates are available Correction dated 2019-05-22
Click to view Correction: https://doi.org/10.1186/s12920-019-0523-6
-
Authors
,
Miller, Jason E.
Metpally, Raghu P.
Person, Thomas N.
Krishnamurthy, Sarathbabu
Dasari, Venkata Ramesh
Shivakumar, Manu
Lavage, Daniel R.
Cook, Adam M.
Carey, David J.
Ritchie, Marylyn D.
Kim, Dokyoon
Gogoi, Radhika
-
Funding
Funding for this research was provided by:
Geisinger Health System Foundation (SRC-075)
Pennsylvania Department of Health (#SAP 4100070267)
National Human Genome Research Institute (T32HG009495-01)
- License Information
-
More Information
Article History
Received: 30 August 2018
Accepted: 15 April 2019
First Online: 3 May 2019
Change Date: 22 May 2019
Change Type: Correction
Change Details: Following publication of the original article [1], the authors reported that Fig. 1 was not correctly processed during the production process. The correct Fig. 1 is given below.
Ethics approval and consent to participate
: The DiscovEHR cohort enrolled individuals from MyCode, which uses written consent and has previously been described []. This study was deemed to be exempt, therefore no further consent was needed. Geisinger Medical Ethics Committee – Geisinger Health System IRB protocol. “Phenotype validation and Biomarker Discovery Protocol for gynecological disorders”. IRB number 2016–0119 was approved on 03/10/2016.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
